Back
Genmab A/S 10K Form
Sell
30
GMAB
Genmab A/S
Last Price:
$29.45
Seasonality Move:
12.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GMAB News And Ratings
See the #1 stock for the next 7 days that we like better than GMAB
GMAB Financial Statistics
Sales & Book Value
| Annual Sales: | $3.7B |
|---|---|
| Cash Flow: | $288M |
| Price / Cash Flow: | 16.42 |
| Annual Sales: | $9.49 |
| Price / Book: | 3.08 |
Profitability
| EPS (TTM): | 1.54810 |
|---|---|
| Net Income (TTM): | $965.8M |
| Gross Margin: | $3.4B |
| Return on Equity: | 17.69% |
| Return on Assets: | 12.29% |
Genmab A/S Earnings Forecast
Key Genmab A/S Financial Ratios
-
The Gross Profit Margin over the past 27 years for GMAB is 91.69%.
-
The Selling, General & Administrative Expenses for GMAB have been equal to 16.83% of Gross Profit Margin.
-
The Research & Development expenses have been 41.91% of Revenue.
-
The Interest Expense is 6.33% of Operating Income.
-
The Net Earning history of GMAB is 25.89% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 16 years.
Genmab A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GMAB |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0.93 |
|---|---|
| Current Ratio: | 2.02 |
| Quick Ratio: | 1.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.98 |
|---|---|
| Forward P/E Ratio: | 16.16 |
GMAB Technical Analysis vs Fundamental Analysis
Sell
30
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S a Buy or a Sell?
-
Genmab A/S stock is rated a SellThe current Genmab A/S [GMAB] share price is $29.24. The Score for GMAB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.